Adaptation to Ozone in Individuals With Asthma/Exercise-induced Bronchoconstriction
Pulmonary and Vascular Adaptations to a 5-days Exercise Protocol in Ozone in Physically Active Individuals With Asthma and Exercise-induced Bronchoconstriction
1 other identifier
interventional
40
1 country
2
Brief Summary
Researchers found that impairments in the cardiopulmonary system caused by acute exposure to ozone were outweighed by repeated exposures to ozone. The goal of this study is to confirm there will be an adaptation similar to what was previously proved but in individuals with asthma and exercise-induced bronchoconstriction (EIB). The purpose is to examine adaptive responses in a randomized cross-over trial in which physically active individuals will perform submaximal exercise on five days in ozone and filtered air exposures separated by a washout period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable asthma
Started Jan 2021
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2021
CompletedFirst Submitted
Initial submission to the registry
September 28, 2021
CompletedFirst Posted
Study publicly available on registry
November 3, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2023
CompletedJune 2, 2022
May 1, 2022
2 years
September 28, 2021
May 28, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in FEV1 from baseline to 10 minutes after exercise
Measurement of pulmonary function: forced exhaled volume in the first second (FEV1) in liters
Measured at baseline and 10 minutes after each exercise bout
Change in FVC from baseline to 10 minutes after exercise
Measurement of pulmonary function: forced vital capacity (FVC) in liters
Measured at baseline and 10 minutes after each exercise bout
Change in FEF25-75 from baseline to 10 minutes after exercise
Measurement of pulmonary function: forced expiratory flow at 25-75% of pulmonary volume in liters per second (L/s)
Measured at baseline and 10 minutes after each exercise bout
Secondary Outcomes (2)
Change in Pulse Wave Velocity (PWV) from baseline to 20 minutes after exercise
Measured at baseline and 20 minutes after each exercise bout
Change in Fraction of exhaled nitric oxide (FeNO) from baseline to 5 minutes after exercise
Measured at baseline and 5 minutes after each exercise bout
Study Arms (2)
Ozone (O3) group
EXPERIMENTALParticipants of the experimental group will perform sub-maximal exercise (60% of VO2max for 30 minutes) on a cycle ergometer while inhaling 170ppb ozone delivered continuously during each exercise session.
Filtered Air
SHAM COMPARATORParticipants of the sham group will also perform sub-maximal exercise (60% of VO2max for 30 minutes) on a cycle ergometer similar to intervention. However, only in this group, the ozone generator will not be activated so that just filtered air will be delivered to the participant while performing each exercise session.
Interventions
Cycling at 60% of VO2max on a cycle ergometer for 30 minutes
Eligibility Criteria
You may qualify if:
- Recreationally active individuals
- Diagnosed asthma and/or mild exercise-induced bronchoconstriction: defined by an FEV1 fall equal to or greater than 10% but lower than 25% in the eucapnic hyperventilatory test.
- Able to securely perform a maximal exercise test (responded 'no' to all questions on the PAR-Q+ questionnaire)
- Able to communicate in English
You may not qualify if:
- Diagnosed with any cardiorespiratory or vascular diseases
- Pregnant or potentially pregnant
- Non-smoking
- Lower limb musculoskeletal injury or lower limb limitation to cycle on a bicycle ergometer
- Recent respiratory symptoms or upper tract infection within 4 weeks
- On vitamin (e.g., C or E) supplementation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Environmental Physiology Laboratory
Vancouver, British Columbia, V6T 1Z1, Canada
University of British Columbia
Vancouver, British Columbia, V6T 1Z3, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael Koehle, MD PhD
Professor
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Masking Details
- Air quality condition (Ozone and filtered air) will be double-blinded; Participants will not be told at any time before the study completion to which group they are assigned (intervention or sham)
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
September 28, 2021
First Posted
November 3, 2021
Study Start
January 1, 2021
Primary Completion
January 1, 2023
Study Completion
February 1, 2023
Last Updated
June 2, 2022
Record last verified: 2022-05
Data Sharing
- IPD Sharing
- Will not share